Skip to main content

Table 1 Clinical characteristics of patients were compared according to surgical outcome

From: Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study

Clinical characteristics

All (83)

Optimal (52)

Suboptimal (31)

P

Age

53.75 ± 10.51

52.13 ± 9.81

56.45 ± 11.24

0.070

FIGO stage

 III

74 (89.16%)

46 (88.46%)

28 (90.32%)

0.791

 IV

9 (10.84%)

6 (11.54%)

3 (9.68%)

 

Tumor grade

 1–2

28 (33.73%)

18 (34.62%)

10 (32.26%)

0.826

 3

55 (66.27%)

34 (65.38%)

21 (67.74%)

 

Histology

 Serous

68 (81.93%)

45 (86.54%)

23 (74.19%)

0.157

 Others

15 (18.07%)

7 (13.46%)

8 (25.81%)

 

 Preoperative serum CA125 level(U/ml)

1260.84 ± 1542.01

1285.57 ± 1662.24

1219.36 ± 1341.36

0.851

 Preoperative serum HE4 level (pmol/L)

635.65 ± 749.15

419.96 ± 355.56

997.44 ± 1050.33

0.006*

ECOG performance status

 0

69 (83.13%)

45 (86.54%)

24 (77.42%)

0.131

 1

9 (10.84%)

6 (11.54%)

3 (9.68%)

 

 2

5 (6.03%)

1 (1.92%)

4 (12.90%)

 

ASA

 1

9 (10.84%)

5 (9.61%)

4 (12.90%)

0.886

 2

69 (83.13%)

44 (84.62%)

25 (80.65%)

 

 ≥ 3

5 (6.03%)

3 (5.77%)

2 (6.45%)

 
  1. Continuous data are represented by means ± standard deviations, while classified data are represented by values and percentages
  2. “*” means P < 0.05